A deadly fungal epidemic in Brazil is evolving fast: pollution, cats, and genetics may be fueling its unstoppable spread.

SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy, ...

Given the types of proteins induced in the TME, such as the Secreted Protein and Rich in Cysteine (SPARC) and glycoprotein 60 (GP60), several types of cancer, such as non-small cell lung cancer ...

A new study published in Mycology highlights the alarming evolutionary rate of Sporothrix, the fungus that causes ...

PRINCETON, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company ...

Sonnet BioTherapeutics Holdings, Inc. announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a new patent related to its modified form of Interleukin-18 ...

Martha graduated from University of Cambridge with a BA in Natural Sciences and went on to do a PhD in cell biology at University College London. She then undertook postdoctoral work at Massachusetts ...

Department of Materials Science and Engineering, Drexel University, Philadelphia, Pennsylvania 19104, United States ...